The Hunter Medical Research Institute has launched a web platform that will help unravel the mysteries behind undiagnosed intellectual disabilities in children.
The NHMRC Clinical Trial Centre will use technology company Medidata's unified platform and analytics for all major new studies starting in 2018.
A powerful computational tool has been developed for antimicrobial pharmacological research into one of the world's most dangerous superbugs.
Newcastle researchers have developed what is claimed to be the world's first virtual platform to host 3D copies of human cancer tissues.
DocuVault is secure, robust and enterprise-friendly document management software that supports major documents' formats and allows for seamless integration with ERP systems and accounting software.
Image-Pro Premier, by Media Cybernetics, is a 2D image analysis software package that offers intuitive tools that make it easy to capture, process, count, measure, analyse and share images and valuable data.
US researchers have developed a tool that helps newly trained scientists evaluate various career paths, separating employment trends in biomedical science by sector, type and job specifics.
Virtual reality technology is allowing multiple scientists to see inside a human cell at the same time, giving researchers a 3D tool to improve doctor interaction and help analyse how cancer drugs work.
Artificially intelligent computer algorithms have been found to equal human pathologists in detecting metastases of breast cancer in lymph nodes.
Australian epilepsy researchers have used a mobile, brain-inspired processor to bring personalised seizure prediction a step closer to a reality.
Seeking to move neuroscience research into the fast lane, researchers at the RIKEN Brain Science Institute have constructed and deployed a high-throughput system to study mouse behaviour and physiology at a much faster rate than that achieved via manual methods.
Supercomputer simulations have revealed the role of transport proteins called efflux pumps in creating drug resistance in bacteria — a breakthrough that could help improve drugs' effectiveness against life-threatening diseases and restore the efficacy of defunct antibiotics.